Insider Trading activities at Cara Therapeutics, Inc. (CARA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cara Therapeutics, Inc. (CARA) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cara Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1346830.

Total stock buying since 2014: $19,306,299.
Total stock sales since 2014: $27,145,563.
Total stock option exercises since 2014: $1,726,874.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Cara Therapeutics, Inc.* (*CARA*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2025	0	$0	955	$4,524	0	$0
2024	0	$0	65,254	$39,941	0	$0
2023	0	$0	80,616	$430,464	0	$0
2022	0	$0	43,536	$460,519	0	$0
2021	0	$0	99,894	$1,708,126	0	$0
2020	0	$0	141,724	$2,232,494	13,500	$134,190
2019	0	$0	308,118	$6,356,245	68,472	$831,615
2018	0	$0	237,151	$4,301,330	85,084	$573,600
2017	500,000	$9,095,500	297,000	$7,217,560	54,000	$133,000
2016	800,000	$3,898,316	68,986	$1,034,793	28,000	$39,469
2015	5,000	$103,500	299,159	$3,359,567	20,000	$5,000
2014	564,453	$6,208,983	0	$0	40,000	$10,000

Table 2. Monthly summary of insider trading at *Cara Therapeutics, Inc.* (*CARA*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2025-02	0	$0	955	$4,524	0	$0
2024-11	0	$0	3,668	$1,063	0	$0
2024-08	0	$0	4,149	$1,452	0	$0
2024-05	0	$0	3,936	$2,952	0	$0
2024-04	0	$0	5,506	$4,568	0	$0
2024-02	0	$0	47,995	$29,906	0	$0
2023-11	0	$0	3,796	$4,631	0	$0
2023-08	0	$0	4,307	$13,222	0	$0
2023-06	0	$0	8,199	$28,777	0	$0
2023-05	0	$0	3,869	$17,023	0	$0
2023-04	0	$0	7,695	$37,781	0	$0
2023-03	0	$0	25,266	$245,330	0	$0
2023-02	0	$0	27,484	$83,700	0	$0
2022-12	0	$0	9,059	$102,093	0	$0
2022-09	0	$0	10,800	$111,024	0	$0
2022-07	0	$0	10,800	$97,740	0	$0
2022-04	0	$0	7,074	$85,775	0	$0
2022-03	0	$0	3,831	$43,596	0	$0
2022-02	0	$0	1,972	$20,291	0	$0
2021-11	0	$0	9,180	$148,357	0	$0
2021-10	0	$0	1,000	$15,000	0	$0
2021-09	0	$0	20,000	$309,400	0	$0
2021-08	0	$0	18,138	$257,558	0	$0
2021-06	0	$0	4,824	$62,930	0	$0

Table 3. Detailed insider trading at *Cara Therapeutics, Inc.* (*CARA*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2025-02-28	Posner Christopher (PRESIDENT AND CEO)	Sale	583	4.75	2,769
2025-02-04	Posner Christopher (PRESIDENT AND CEO)	Sale	372	4.72	1,755
2024-11-04	Posner Christopher (PRESIDENT AND CEO)	Sale	3,668	.29	1,063
2024-08-01	Posner Christopher (PRESIDENT AND CEO)	Sale	4,149	.35	1,452
2024-05-02	Posner Christopher (PRESIDENT AND CEO)	Sale	3,936	.75	2,952
2024-04-05	Goncalves Joana (CHIEF MEDICAL OFFICER)	Sale	2,753	.83	2,284
2024-04-05	Terrillion Scott (SEC'Y; CHIEF COMPLIANCE & G.C.)	Sale	2,753	.83	2,284
2024-02-29	Goncalves Joana (CHIEF MEDICAL OFFICER)	Sale	3,293	.89	2,930
2024-02-29	Posner Christopher (PRESIDENT AND CEO)	Sale	5,834	.89	5,192
2024-02-29	Terrillion Scott (SEC'Y; CHIEF COMPLIANCE & G.C.)	Sale	3,293	.89	2,930
2024-02-08	Posner Christopher (PRESIDENT AND CEO)	Sale	35,575	.53	18,854
2023-11-02	Posner Christopher (President and CEO)	Sale	3,796	1.22	4,631
2023-08-03	Posner Christopher (President and CEO)	Sale	4,307	3.07	13,222
2023-06-23	Goncalves Joana (Chief Medical Officer)	Sale	2,723	3.51	9,557
2023-06-23	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	2,483	3.51	8,715
2023-06-23	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	2,993	3.51	10,505
2023-05-05	Posner Christopher (President and CEO)	Sale	3,869	4.40	17,023
2023-04-04	Goncalves Joana (Chief Medical Officer)	Sale	2,481	4.91	12,181
2023-04-04	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	2,481	4.91	12,181
2023-04-04	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	2,733	4.91	13,419
2023-03-03	Goncalves Joana (Chief Medical Officer)	Sale	6,221	9.71	60,405
2023-03-03	Posner Christopher (President and CEO)	Sale	5,987	9.71	58,133
2023-03-03	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	6,256	9.71	60,745
2023-03-03	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	6,802	9.71	66,047
2023-02-16	Goncalves Joana (Chief Medical Officer)	Sale	2,265	10.20	23,103
2023-02-08	Goncalves Joana (CHIEF MEDICAL OFFICER)	Sale	7,770	.53	4,118
2023-02-08	Terrillion Scott (SEC'Y; CHIEF COMPLIANCE & G.C.)	Sale	7,770	.53	4,118
2023-02-08	Maynard Ryan D (CHIEF FINANCIAL OFFICER)	Sale	5,488	.53	2,908
2023-02-02	Posner Christopher (President and CEO)	Sale	4,191	11.80	49,453
2022-12-21	Goncalves Joana (Chief Medical Officer)	Sale	2,992	11.27	33,719
2022-12-21	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	2,561	11.27	28,862
2022-12-21	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	3,506	11.27	39,512
2022-09-14	Vogelbaum Martin (Director)	Sale	10,800	10.28	111,024
2022-07-15	Ives Jeffrey L. (Director)	Sale	3,600	9.05	32,580
2022-07-15	Bains Harrison M Jr (Director)	Sale	7,200	9.05	65,160
2022-04-04	Posner Christopher (President and CEO)	Sale	2,006	12.67	25,416
2022-04-01	Goncalves Joana (Chief Medical Officer)	Sale	1,642	11.91	19,556
2022-04-01	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	1,642	11.91	19,556
2022-04-01	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	1,784	11.91	21,247
2022-03-03	Reilly Thomas Charles (Chief Financial Officer)	Sale	2,044	11.38	23,260
2022-03-03	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	1,787	11.38	20,336
2022-02-25	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	1,972	10.29	20,291
2021-11-12	Ives Jeffrey L. (Director)	Sale	8,180	16.04	131,207
2021-11-01	Goncalves Joana (Chief Medical Officer)	Sale	1,000	17.15	17,150
2021-10-27	Goncalves Joana (Chief Medical Officer)	Sale	1,000	15.00	15,000
2021-09-07	Chalmers Derek T (President & CEO)	Sale	20,000	15.47	309,400
2021-08-30	Reilly Thomas Charles (Chief Financial Officer)	Sale	1,982	14.20	28,144
2021-08-30	Goncalves Joana (Chief Medical Officer)	Sale	2,110	14.20	29,962
2021-08-30	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	1,759	14.20	24,977
2021-08-30	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	3,847	14.20	54,627
2021-08-30	Chalmers Derek T (President & CEO)	Sale	8,440	14.20	119,848
2021-06-07	Posner Christopher (Director)	Sale	2,304	13.04	30,044
2021-06-07	Ives Jeffrey L. (Director)	Sale	2,520	13.05	32,886
2021-04-21	Goncalves Joana (Chief Medical Officer)	Sale	3,000	27.63	82,890
2021-03-22	Goncalves Joana (Chief Medical Officer)	Sale	3,000	19.65	58,949
2021-03-05	Goncalves Joana (Chief Medical Officer)	Sale	3,093	17.98	55,612
2021-03-05	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	3,090	17.98	55,558
2021-03-05	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	3,358	17.98	60,376
2021-03-05	Chalmers Derek T (President & CEO)	Sale	3,103	17.98	55,791
2021-02-25	Goncalves Joana (Chief Medical Officer)	Sale	3,372	19.33	65,180
2021-02-25	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	4,004	19.33	77,397
2021-02-25	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	5,003	19.33	96,707
2021-02-25	Chalmers Derek T (President & CEO)	Sale	11,729	19.33	226,721
2021-02-22	Goncalves Joana (Chief Medical Officer)	Sale	2,000	19.73	39,460
2021-01-21	Goncalves Joana (Chief Medical Officer)	Sale	2,000	20.12	40,240
2020-12-30	Goncalves Joana (Chief Medical Officer)	Sale	1,298	15.30	19,859
2020-12-30	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	1,946	15.30	29,773
2020-12-30	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	2,812	15.30	43,023
2020-12-30	Chalmers Derek T (President & CEO)	Sale	6,078	15.30	92,993
2020-12-28	Chalmers Derek T (President & CEO)	Sale	5,000	16.00	80,000
2020-12-21	Goncalves Joana (Chief Medical Officer)	Sale	2,000	15.00	30,000
2020-12-16	Chalmers Derek T (President & CEO)	Sale	5,000	14.95	74,750
2020-12-10	Chalmers Derek T (President & CEO)	Sale	7,500	15.29	114,675
2020-11-23	Goncalves Joana (Chief Medical Officer)	Sale	2,000	15.31	30,620
2020-11-19	Posner Christopher (Director)	Sale	2,000	15.82	31,638
2020-11-17	Vogelbaum Martin (Director)	Sale	6,000	16.09	96,540
2020-11-17	Chalmers Derek T (President & CEO)	Sale	11,799	16.00	188,784
2020-11-10	Goncalves Joana (Chief Medical Officer)	Sale	2,000	15.00	30,000
2020-10-20	Goncalves Joana (Chief Medical Officer)	Sale	2,000	15.00	30,000
2020-09-03	Chalmers Derek T (President & CEO)	Sale	3,201	16.00	51,216
2020-08-03	Chalmers Derek T (President & CEO)	Sale	5,000	16.42	82,100
2020-07-01	Chalmers Derek T (President & CEO)	Sale	5,000	17.11	85,550
2020-06-12	Goncalves Joana (Chief Medical Officer)	Sale	10,627	15.20	161,530
2020-06-03	Chalmers Derek T (President & CEO)	Sale	4,300	16.01	68,843
2020-06-01	Ives Jeffrey L. (Director)	Sale	1,000	16.00	16,000
2020-06-01	Ives Jeffrey L. (Director)	Option Ex	1,000	9.94	9,940
2020-06-01	Chalmers Derek T (President & CEO)	Sale	700	16.00	11,200
2020-05-22	Chalmers Derek T (President & CEO)	Sale	371	16.00	5,936
2020-05-21	Chalmers Derek T (President & CEO)	Sale	3,500	16.00	56,000
2020-05-20	Chalmers Derek T (President & CEO)	Sale	1,200	16.00	19,200
2020-05-12	Ives Jeffrey L. (Director)	Sale	2,500	16.00	40,000
2020-05-12	Ives Jeffrey L. (Director)	Option Ex	2,500	9.94	24,850
2020-05-12	Chalmers Derek T (President & CEO)	Sale	4,929	16.00	78,864
2020-04-21	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	2,721	15.56	42,338
2020-04-21	Ives Jeffrey L. (Director)	Sale	2,500	16.00	40,000
2020-04-21	Ives Jeffrey L. (Director)	Option Ex	2,500	9.94	24,850
2020-04-21	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	12,894	15.58	200,888
2020-04-21	Chalmers Derek T (President & CEO)	Sale	6,348	15.56	98,774
2020-03-04	Ives Jeffrey L. (Director)	Sale	2,500	16.00	40,000
2020-03-04	Ives Jeffrey L. (Director)	Option Ex	2,500	9.94	24,850
2020-02-03	Ives Jeffrey L. (Director)	Sale	2,500	16.23	40,575
2020-02-03	Ives Jeffrey L. (Director)	Option Ex	2,500	9.94	24,850
2020-01-02	Ives Jeffrey L. (Director)	Sale	2,500	16.13	40,325
2020-01-02	Ives Jeffrey L. (Director)	Option Ex	2,500	9.94	24,850
2020-01-02	Chalmers Derek T (President & CEO)	Sale	10,000	16.05	160,500
2019-12-04	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	3,980	17.05	67,859
2019-12-04	Mohindru Mani (CFO & Chief Strategy Officer)	Sale	4,755	17.05	81,072
2019-12-04	Chalmers Derek T (President & CEO)	Sale	10,699	17.05	182,417
2019-12-02	Ives Jeffrey L. (Director)	Sale	2,500	25.83	64,574
2019-12-02	Ives Jeffrey L. (Director)	Option Ex	2,500	5.32	13,300
2019-12-02	Chalmers Derek T (President & CEO)	Sale	10,000	25.79	257,900
2019-11-01	Ives Jeffrey L. (Director)	Sale	2,500	20.68	51,700
2019-11-01	Ives Jeffrey L. (Director)	Option Ex	2,500	5.32	13,300
2019-11-01	Chalmers Derek T (President & CEO)	Sale	5,000	20.79	103,950
2019-10-25	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	4,000	19.91	79,640
2019-10-18	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	4,000	19.33	77,320
2019-10-11	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	4,000	18.70	74,800
2019-10-04	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	4,000	19.19	76,760
2019-10-01	Ives Jeffrey L. (Director)	Sale	2,500	18.21	45,525
2019-10-01	Ives Jeffrey L. (Director)	Option Ex	2,500	5.32	13,300
2019-10-01	Chalmers Derek T (President & CEO)	Sale	10,000	18.28	182,800
2019-09-03	Ives Jeffrey L. (Director)	Sale	2,500	23.31	58,275
2019-09-03	Ives Jeffrey L. (Director)	Option Ex	2,500	5.32	13,300
2019-09-03	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	20,000	22.92	458,400
2019-09-03	Chalmers Derek T (President & CEO)	Sale	5,000	23.26	116,300
2019-08-01	Ives Jeffrey L. (Director)	Sale	2,500	23.24	58,099
2019-08-01	Ives Jeffrey L. (Director)	Option Ex	2,500	5.32	13,300
2019-08-01	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	20,000	23.24	464,799
2019-08-01	Chalmers Derek T (President & CEO)	Sale	10,000	23.27	232,700
2019-07-17	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	8,996	27.50	247,390
2019-07-15	Mohindru Mani (CFO & Chief Strategy Officer)	Sale	37,431	25.00	935,775
2019-07-15	Mohindru Mani (CFO & Chief Strategy Officer)	Option Ex	37,431	14.06	526,279
2019-07-01	Ives Jeffrey L. (Director)	Sale	2,500	21.75	54,375
2019-07-01	Ives Jeffrey L. (Director)	Option Ex	2,500	5.32	13,300
2019-07-01	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	20,000	21.90	438,000
2019-05-29	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	2,303	21.38	49,238
2019-05-29	Mohindru Mani (CFO & Chief Strategy Officer)	Sale	2,496	21.39	53,389
2019-05-29	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	11,397	21.19	241,502
2019-05-29	Chalmers Derek T (President & CEO)	Sale	5,528	21.42	118,409
2019-03-13	Mohindru Mani (CFO & Chief Strategy Officer)	Sale	16,041	19.12	306,703
2019-03-13	Mohindru Mani (CFO & Chief Strategy Officer)	Option Ex	16,041	14.06	225,536
2019-03-13	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	16,803	18.87	317,072
2019-03-12	Menzaghi Frederique Ph.d. (Chief Scientific Off,SVP-R&D)	Sale	3,197	17.50	55,947
2019-03-01	Chalmers Derek T (President & CEO)	Sale	9,792	17.04	166,855
2019-02-28	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	1,500	17.50	26,250
2019-02-25	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	2,200	17.50	38,500
2019-02-01	Chalmers Derek T (President & CEO)	Sale	20,000	14.99	299,800
2019-01-04	Chalmers Derek T (President & CEO)	Sale	5,000	15.04	75,200
2019-01-02	Chalmers Derek T (President & CEO)	Sale	15,000	13.13	196,950
2018-12-28	Terrillion Scott (Sec'y; Chief Compliance & G.C.)	Sale	3,100	12.51	38,781
2018-12-28	Mohindru Mani (CFO & Chief Strategy Officer)	Sale	4,500	12.55	56,475
2018-12-28	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	4,300	12.53	53,879
2018-12-28	Chalmers Derek T (President & CEO)	Sale	15,825	12.53	198,287
2018-12-03	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	3,000	18.36	55,080
2018-12-03	Chalmers Derek T (President & CEO)	Sale	20,000	18.17	363,400
2018-11-15	Mohindru Mani (CFO & Chief Strategy Officer)	Sale	16,042	18.50	296,777
2018-11-15	Mohindru Mani (CFO & Chief Strategy Officer)	Option Ex	16,042	14.06	225,550
2018-11-01	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	3,000	18.77	56,310
2018-11-01	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Option Ex	40,000	2.05	82,000
2018-11-01	Chalmers Derek T (President & CEO)	Sale	20,000	18.78	375,600
2018-10-17	Mohindru Mani (CFO & Chief Strategy Officer)	Sale	16,042	20.19	323,887
2018-10-17	Mohindru Mani (CFO & Chief Strategy Officer)	Option Ex	16,042	14.06	225,550
2018-10-17	Stauffer Joseph William (Chief Medical Officer)	Sale	11,442	20.39	233,245
2018-10-01	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	3,000	23.99	71,970
2018-10-01	Chalmers Derek T (President & CEO)	Sale	20,000	23.79	475,800
2018-09-04	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	3,000	19.81	59,429
2018-09-04	Chalmers Derek T (President & CEO)	Sale	20,000	19.71	394,200
2018-08-20	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	3,000	18.89	56,670
2018-08-06	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Option Ex	10,000	2.25	22,500
2018-07-10	Chalmers Derek T (President & CEO)	Sale	20,000	20.64	412,800
2018-07-02	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	3,000	19.00	57,000
2018-06-01	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	3,000	15.49	46,470
2018-05-23	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	9,000	15.19	136,710
2018-02-16	Chalmers Derek T (President & CEO)	Sale	5,400	15.00	81,000
2018-02-15	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	3,000	15.02	45,060
2018-01-25	Chalmers Derek T (President & CEO)	Option Ex	3,000	6.00	18,000
2018-01-24	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Sale	15,000	15.00	225,000
2018-01-24	Chalmers Derek T (President & CEO)	Sale	12,500	15.00	187,500
2017-11-07	Menzaghi Frederique Ph.d. (Sr VP-Research & Development)	Option Ex	20,000	2.48	49,600
2017-11-03	Chalmers Derek T (President & CEO)	Option Ex	20,000	2.48	49,600
2017-11-01	Chalmers Derek T (President & CEO)	Sale	16,000	12.66	202,560
2017-08-04	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	3,000	15.00	45,000
2017-07-26	Schoell Josef (Chief Financial Officer)	Option Ex	4,000	2.25	9,000
2017-07-14	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	3,000	15.00	45,000
2017-07-14	Chalmers Derek T (President & CEO)	Sale	25,000	15.05	376,250
2017-07-14	Chalmers Derek T (President & CEO)	Option Ex	10,000	2.48	24,800
2017-06-29	Slagel Dean (Director)	Sale	250,000	26.20	6,548,750
2017-03-31	Ruch Joshua	Buy	500,000	18.19	9,095,500
2016-04-20	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	6,000	9.00	54,000
2016-03-17	Vogelbaum Martin	Buy	247,727	4.93	1,221,294
2016-03-17	Kairouz Habib	Buy	247,727	4.93	1,221,294
2016-03-16	Schoell Josef (Chief Financial Officer)	Option Ex	18,000	.81	14,669
2016-03-16	Vogelbaum Martin	Buy	152,273	4.78	727,864
2016-03-16	Kairouz Habib	Buy	152,273	4.78	727,864
2016-03-15	Chalmers Derek T (President & CEO)	Option Ex	10,000	2.48	24,800
2016-02-03	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	1,000	9.00	9,000
2016-02-01	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	5,000	9.05	45,250
2016-01-26	Lewis Michael E (Chief Scientific Advisor)	Sale	7,262	10.93	79,373
2016-01-06	Chalmers Derek T (President & CEO)	Sale	12,500	17.22	215,250
2016-01-05	Slagel Dean (Director)	Sale	31,224	17.01	531,120
2016-01-04	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	6,000	16.80	100,800
2015-12-31	Slagel Dean (Director)	Sale	12,776	17.00	217,192
2015-12-01	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	6,000	16.21	97,260
2015-11-02	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	6,000	14.26	85,560
2015-10-01	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	6,000	14.12	84,690
2015-09-01	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	7,000	18.63	130,410
2015-08-18	Schoell Josef (Chief Financial Officer)	Buy	3,000	22.10	66,300
2015-08-04	Stauffer Joseph William (Chief Medical Officer)	Buy	2,000	18.60	37,200
2015-08-03	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	7,000	21.41	149,870
2015-07-01	Menzaghi Frederique Ph.d. (VP-Research & Development)	Sale	7,000	12.22	85,540
2015-07-01	Lewis Michael E (Chief Scientific Advisor)	Sale	7,262	11.66	84,674
2015-06-01	Lewis Michael E (Chief Scientific Advisor)	Sale	7,262	9.50	68,989
2015-05-19	Slagel Dean (Director)	Sale	32,266	10.00	322,660
2015-05-18	Slagel Dean (Director)	Sale	82,945	10.04	832,767
2015-05-15	Slagel Dean (Director)	Sale	73,600	10.00	736,000
2015-05-01	Lewis Michael E (Chief Scientific Advisor)	Sale	7,262	10.64	77,267
2015-04-01	Lewis Michael E (Chief Scientific Advisor)	Sale	7,262	9.90	71,893
2015-03-09	Menzaghi Frederique Ph.d. (VP-Research & Development)	Option Ex	20,000	.25	5,000
2015-03-02	Lewis Michael E (Chief Scientific Advisor)	Sale	7,262	10.11	73,418
2015-02-17	Schoell Josef (Chief Financial Officer)	Sale	15,000	10.96	164,400
2015-02-02	Lewis Michael E (Chief Scientific Advisor)	Sale	7,262	10.60	76,977
2014-08-14	Schoell Josef (Chief Financial Officer)	Option Ex	40,000	.25	10,000
2014-02-05	Vogelbaum Martin (Director)	Buy	225,818	11.00	2,483,998
2014-02-05	Penhoet Edward (10% Owner)	Buy	112,817	11.00	1,240,987
2014-02-05	Ruch Joshua (10% Owner)	Buy	225,818	11.00	2,483,998

Insider trading activities including stock purchases, stock sales, and option exercises of CARA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cara Therapeutics, Inc. (symbol CARA, CIK number 1346830) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month